Subtotal
$0.00
Shipping
$0
Taxes
$0
Total
$0.00
LuciEntre
LuciEntre
$637.16
$800.00
Adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
Qty
COMPOSITION:
Each LuciEntre capsule contains: Entrectinib ……. 100mg
INDICATION:
LuciEntre is a kinase inhibitor indicated for the treatment of:
• Adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
• Adult and pediatric patients 12 years of age and older with solid tumors that:
- - have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion as detected by an FDA-approved test without a known acquired resistance mutation,
- - are metastatic or where surgical resection is likely to result in severe morbidity, and
- - have progressed following treatment or have no satisfactory alternative therapy.
DOSAGE AND USE:
• Recommended Dosage for ROS1-Positive Non-Small Cell Lung Cancer: 600 mg orally once daily.
• Recommended Dosage for NTRK Gene Fusion-Positive Solid Tumors:
Adults: 600mg orally once daily.
Pediatric Patients 12 Years and Older: Recommended dosage is based on body surface area (BSA) as shown below
□ BSA greater than 1.50 m2: 600 mg once daily.
□ BSA 1.11 to 1.50 m2: 500 mg once daily.
□ BSA 0.91 to 1.10 m2: 400 mg once daily.
Capsules should be swallowed whole & not chewed or crushed.
STORAGE:
in a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY:
LUCIUS PHARMACEUTICALS(LAO) CO., LTD
No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING:
Keep medicine out of reach of Children. Do not administer LuciEntre during Pregnancy and Lactation.
Customer Reviews
Based on 1 review
Write a review
Write a review
Cobus Bester
Cobus Bester on Mar 03, 2023
Can’t wait to start mixin’ with this one! Irba-irr-Up-up-up-up-date your theme!
Report as InappropriateRelated Products
.jpeg)
.jpg)
